Meta-Analysis Evaluating the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction According to Baseline Anemia

Am J Cardiol. 2022 Sep 15:179:111-114. doi: 10.1016/j.amjcard.2022.06.011. Epub 2022 Jul 22.

Authors

Dimitrios Patoulias¹, Christodoulos Papadopoulos², Nikolaos Fragakis², Asterios Karagiannis¹, Michael Doumas¹

Affiliations

¹ Second Propaedeutic Department of Internal Medicine.
² Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital "Hippokration," Thessaloniki, Greece.

PMID: 35871863
DOI: 10.1016/j.amjcard.2022.06.011

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

Anemia*
Diabetes Mellitus, Type 2*
Glucose
Heart Failure*
Humans
Sodium
Sodium-Glucose Transporter 2 Inhibitors*
Stroke Volume
Symporters*

Substances

Sodium-Glucose Transporter 2 Inhibitors
Symporters
Sodium
Glucose